ArticleThe oncologist2020

Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib.

Ching-Yao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.